RUA Life Sciences plc (AIM:RUA)

London flag London · Delayed Price · Currency is GBP · Price in GBX
19.58
+0.83 (4.43%)
Apr 28, 2026, 3:59 PM GMT
68.43%
Market Cap 11.64M
Revenue (ttm) 4.46M
Net Income (ttm) -145.33K
Shares Out 62.06M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 202,755
Average Volume 344,587
Open 18.97
Previous Close 18.75
Day's Range 18.97 - 19.95
52-Week Range 10.42 - 20.00
Beta 0.63
RSI 74.85
Earnings Date Jun 25, 2026

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric. It also enga... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1996
Employees 59
Stock Exchange London Stock Exchange AIM
Ticker Symbol RUA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.